M&A Deal Summary |
|
|---|---|
| Date | 2021-05-17 |
| Target | Los Sueños Farms |
| Sector | Agriculture |
| Buyer(s) | Curaleaf |
| Deal Type | Add-on Acquisition |
| Deal Value | 67M USD |
SEARCH BY
| Category | Company |
|---|---|
| Founded | 2010 |
| Sector | Consumer Products |
| Employees | 5,519 |
| Revenue | 1.3B USD (2024) |
Curaleaf is a vertically integrated multi-state cannabis operator with a dominant presence on both the east and west coasts of the United States, the largest cannabis market in the world. Curaleaf was founded in 2010 and is based in Stamford, Connecticut.
| DEAL STATS | # |
|---|---|
| Overall | 10 of 17 |
| Sector: Agriculture M&A | 2 of 2 |
| Type: Add-on Acquisition M&A Deals | 10 of 16 |
| State: Colorado M&A | 2 of 2 |
| Country: United States M&A | 9 of 13 |
| Year: 2021 M&A | 2 of 5 |
| Size (of disclosed) | 6 of 8 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2021-03-09 |
EMMAC Life Sciences
London, United Kingdom EMMAC Life Sciences Ltd. is the largest vertically integrated independent cannabis company in Europe, bringing together pioneering science and research with cutting-edge cultivation, extraction, and production. With a unique supply and distribution network throughout Europe, EMMAC's vision is to bring the life-enhancing potential of cannabis to the people who need it. EMMAC Life Sciences Ltd. was founded in 2018 and is based in London, United Kingdom. |
Buy | $343M |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2021-10-01 |
Curaleaf International
London, United Kingdom Curaleaf International offers a comprehensive suite of EU GMP-certified medical cannabis products and services. Curaleaf International is based in London, United Kingdom. |
Buy | - |
